Dazodalibep

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Safety and EfficacySjögren's Syndrome

130 competitors in Safety and Efficacy

#DrugCompanyPhaseTrials

1

Avastin

Roche

Phase 3

32

Actemra

Roche

Phase 3

13

Humira

RRanbaxy Laboratories Limited

Phase 3

34

Rayos

RRoxane Laboratories

Phase 3

35

Empaveli

Apellis Pharmaceuticals

Phase 3

26

Gemzar

Johnson & Johnson

Phase 2

67

Fludara

Sanofi

Phase 2

58

CAB LA

GSK

Phase 3

19

Yervoy

Bristol-Myers Squibb

Phase 2

310

Tagrisso

AstraZeneca

Phase 2

3Show 38 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Safety and Efficacy1 trial

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Active, not recruiting·Amgen·Phase 3·NCT06245408·434 enrolled

Sjögren's Syndrome1 trial

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Recruiting·Amgen·Phase 3·NCT06747949·844 enrolled

Sjogren's Syndrome1 trial

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity

Completed·Amgen·Phase 3·NCT06104124·651 enrolled

Details

Drug Info

Related News